Delivery Order SPE2DB20D3103-SPE2DB23FL9M9
Award Date 12/19/22
Potential Completion Date 12/20/22
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,437.19, is a Firm Fixed Price Delivery Order for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $4,664.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $7,422.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, with a completion date of August 14, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,054.32 delivery order is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a prescription medication. The contract has an ultimate completion date of April 24, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $21,075.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. As a general...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,266.85, is a Firm Fixed Price Delivery Order for the supply of REBIF 22 MCG/0.5 ML SYRINGE 0.5ML medical products. The award has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $35,268.40 delivery order contract is for the supply of Rebif 44 mcg/0.5 mL syringes, a multiple sclerosis medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award, valued at $4,101.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC), covers the provision of REBIF SYR 0.5ML 12S, a pharmaceutical product. The contract has a firm fixed price and is set to run until November 13, 2024. While the original solicitation is not provided, the contract appears to be part of a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,796.32, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,646.17 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 7, 2022, with a completion date of July 8, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to...